Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 420 results found. Search for [ coronavirus stages ]

Results 40 to 60 of 420
BusinessToday.In
December 22, 2020
If needed, the company could provide a new vaccine technically within six weeks to deal with the new mutated strain detected in Britain, says BioNTech CEO Ugur Sahin


BusinessToday.In
December 21, 2020
Tech spend is expected to increase to $2.9 trillion by 2021. We are looking at a seismic shift in the scaling of digitization at a pace never seen before, said Rakesh Rathi


BusinessToday.In
December 20, 2020
As many as 341 new fatalities were reported in the past 24 hours, pushing the overall death toll to 1,45,477.  India's COVID-19 case fatality rate is 1.45 per cent, which is one of the lowest in the world


BusinessToday.In
December 19, 2020
Despite the rise in cases, India's Covid-19 recoveries have witnessed a steep exponential rise -- from 50,000 in May to over 95 lakh in December. Recoveries are more than 30 times active cases, says  HealthMin


BusinessToday.In
December 18, 2020
COVID-19 vaccine will be introduced only when the safety is proven. As is true for other vaccines, the common side effects in some individuals could be mild fever, pain, etc. at the site of injection, said the ministry


PTI
December 17, 2020
Alka Sharma, an adviser with the Department of Biotechnology said more than 100 participants from Afghanistan, Bhutan, Maldives, Mauritius, Nepal, Sri Lanka took part in this training programme


BusinessToday.In
December 15, 2020
London will move to Tier 3 \"very high alert\" local restrictions on Wednesday. Under this, all hospitality venues, including restaurants, pubs, bars, cafes will be shut except for takeout and delivery


BusinessToday.In
December 13, 2020
VK Paul says globally, 33 vaccines are in clinical trial phase, of which 10 vaccines are in advanced trial phase. Key consideration while prioritising population for vaccine inoculation is accessing people with risk to mortality and protection of healthcare system and response system


PB Jayakumar
December 11, 2020
As the country plans to vaccinate 30 crore people by July in the first phase, it may be difficult to bank alone on the Indian vaccines, especially Serum Institute's (SII) Covishield


Associated Press
December 10, 2020
The Amsterdam-based European Medicines Agency, which is considering requests for conditional marketing authorisation for several coronavirus vaccines to be used in the 27-nation European Union, said earlier on Wednesday that it had been the target of a cyberattack


Reuters
December 9, 2020
 Union health secretary said there are multiple vaccine candidates in different stages of development and some may get licensed in the next few weeks


BusinessToday.In
December 8, 2020
Union Health Ministry informed that the current cold chain system in India consists of 85,634 equipments for storage of vaccine at about 28,947 cold chain points across the country


BusinessToday.In
December 8, 2020
Although there is not much clarity on the number of doses that would be secured from the Serum Institute of India, approximately 60 million could be made available soon


Chitranjan Kumar
December 7, 2020
The WHO said that journalists need to read the full study or report before publishing an article about it and should be willing to question stakeholders and data collection methodology


BusinessToday.In
December 5, 2020
DCGI VG Somani has said the CDSCO will facilitate analysis of interim clinical trial data at pre-defined stages. PM Modi says nearly eight vaccine candidates, out of which three are indigenously developed, are undergoing trials in India


BusinessToday.In
December 4, 2020
COVID-19 vaccine trial updates: AIIMS director Dr Randeep Guleria has pinned his hopes on the five coronavirus vaccine candidates which are in varying stages of trials across India


BusinessToday.In
December 1, 2020
According to the documents, Hubei had also been dealing with an influenza epidemic towards the end of 2019, which showed a twenty-fold increase in the number of cases as compared to 2018.


BusinessToday.In
November 30, 2020
As number of patients has doubled from 95 to 196, Moderna has reported a drop in efficacy for its COVID-19 vaccine from 94.5 per cent to 94.1 per cent


PTI
November 27, 2020
India assured the people of Nepal that once it rolls out a vaccine against COVID-19, meeting their requirement will be a priority for New Delhi, amid a spike of the deadly disease in the Himalayan nation


PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research


PAGES 3 OF 21  12345